Fine particulate matter (PM2.5): The culprit for chronic lung diseases in China
| Autor: | Lin-Fu Zhou, Zi Chen, Zhou Zhu, Rong Hu, Qiyuan Li, Tao Li, Shouxiong Huang |
|---|---|
| Rok vydání: | 2018 |
| Předmět: |
0301 basic medicine
Medicine (General) medicine.medical_specialty Air pollution 010501 environmental sciences medicine.disease_cause 01 natural sciences 03 medical and health sciences R5-920 Environmental health 11. Sustainability Epidemiology medicine Respiratory system Lung cancer 0105 earth and related environmental sciences Asthma Lung business.industry Particulates medicine.disease 3. Good health 030104 developmental biology medicine.anatomical_structure 13. Climate action business Respiratory tract |
| Zdroj: | Chronic Diseases and Translational Medicine, Vol 4, Iss 3, Pp 176-186 (2018) |
| ISSN: | 2589-0514 |
| Popis: | Air pollution is a world public health problem. Particulate matter (PM), a mix of solid and liquid particles in the air, becomes an increasing concern in the social and economic development of China. For decades, epidemiological studies have confirmed the association between fine particle pollutants and respiratory diseases. It has been reported in different populations that increased fine particulate matter (PM2.5) concentrations cause elevated susceptibility to respiratory diseases, including acute respiratory distress, asthma, chronic obstructive pulmonary disease, and lung cancer. This review will discuss the pathophysiology of PM2.5 in respiratory diseases, which are helpful for the prevention of air pollution and treatment of respiratory tract inflammatory diseases. Keywords: Air pollution, Particulate matter, Lung diseases, Chronic obstructive pulmonary disease |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text